Cargando…
Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection
Half of the world's population is exposed to the risk of dengue virus infection. Although a vaccine for dengue virus is now available in a few countries, its reported overall efficacy of about 60% is not ideal. Protective immune correlates following natural dengue virus infection remain undefin...
Autores principales: | Xu, Meihui, Züst, Roland, Toh, Ying Xiu, Pfaff, Jennifer M., Kahle, Kristen M., Davidson, Edgar, Doranz, Benjamin J., Velumani, Sumathy, Tukijan, Farhana, Wang, Cheng-I, Fink, Katja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126370/ https://www.ncbi.nlm.nih.gov/pubmed/27707930 http://dx.doi.org/10.1128/JVI.01096-16 |
Ejemplares similares
-
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017) -
Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018) -
Serum Metabolomics Investigation of Humanized Mouse Model of Dengue Virus Infection
por: Cui, Liang, et al.
Publicado: (2017) -
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India
por: Chandele, Anmol, et al.
Publicado: (2016) -
Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response
por: Conn, Kristen L., et al.
Publicado: (2016)